Literature DB >> 7006389

Mechanisms of insulin resistance in man. Assessment using the insulin dose-response curve in conjunction with insulin-receptor binding.

R A Rizza, L J Mandarino, J E Gerich.   

Abstract

During the past few years it has become increasingly apparent that insulin resistance may be a more frequent cause of carbohydrate intolerance or contributing factor in carbohydrate intolerance than was hitherto appreciated. Abnormal insulin action may result from prereceptor, receptor or postreceptor defects. These may be manifested by an increase in the concentration of insulin necessary for a half-maximal effect (decreased sensitivity) or a decrease in the maximal response to insulin (decreased responsiveness), or both. Alterations in sensitivity and responsiveness to insulin can be distinguished only by evaluating insulin dose-response curves. When used in conjunction with measurements of insulin binding to its receptor, the characteristics of these curves can provide insight into the mechanism or mechanisms responsible for insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7006389     DOI: 10.1016/0002-9343(81)90423-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids.

Authors:  Ximena Lopez; Aaron Cypess; Raquel Manning; Sheila O'Shea; Rohit N Kulkarni; Allison B Goldfine
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

2.  Defective glucose utilization in patients with functioning beta-cell tumors persists after tumor excision.

Authors:  G S McGee; M M Kulaylat; N N Abumrad
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

3.  Adrenergic system and carbohydrate metabolism. Effects of beta-receptor blockade on insulin secretion and peripheral insulin sensitivity in normoglycaemic patients.

Authors:  L A Ferrara; B Capaldo; A Rivellese; S Genovese; C Iovine; P Mastranzo; F Cirillo; M Mancini
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Insulin resistance in porphyria cutanea tarda.

Authors:  F Calcinaro; G Basta; P Lisi; C Cruciani; M Pietropaolo; F Santeusanio; A Falorni; R Calafiore
Journal:  J Endocrinol Invest       Date:  1989-06       Impact factor: 4.256

5.  Insulin regulates arginine-stimulated insulin secretion in humans.

Authors:  Florencia Halperin; Teresa Mezza; Ping Li; Jun Shirakawa; Rohit N Kulkarni; Allison B Goldfine
Journal:  Metabolism       Date:  2022-01-07       Impact factor: 8.694

6.  A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping.

Authors:  M Ponchner; R J Heine; A Pernet; I Hanning; A J Francis; D Cook; H Orskov; K G Alberti
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

7.  Suppressive mechanisms in alloantigen-induced T cell responses.

Authors:  M Beckwith; S Rich
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

8.  Short-term effects of recombinant human growth hormone and feeding on gluconeogenesis in humans.

Authors:  Walid Kaplan; Agneta L Sunehag; Harry Dao; Morey W Haymond
Journal:  Metabolism       Date:  2008-06       Impact factor: 8.694

9.  Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans.

Authors:  Florencia Halperin; Ximena Lopez; Raquel Manning; C Ronald Kahn; Rohit N Kulkarni; Allison B Goldfine
Journal:  Diabetes       Date:  2012-02       Impact factor: 9.461

10.  Postprandial 2-hr C-peptide concentration as a guide for insulin treatment in patient with NIDDM.

Authors:  R S Kim; I M Yang; J W Kim; Y S Kim; K W Kim; S W Kim; Y K Choi
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.